Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Icade Capital/Financing Update 2021

Sep 30, 2021

1424_iss_2021-09-30_0eb2a2da-6c0a-4d09-88c6-6f3e1f109605.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Paris, September 30, 2021 – 7:00pm

Icade Santé's IPO:

Order book covered in an uncertain and volatile market environment Icade and Icade Santé will come back to the market in the next few days to specify the follow-up to the transaction

Paris, September 30, 2021 - After an active week of roadshows and six days of book building, the order book was covered on Wednesday, September 29 in the afternoon.

However, current equity market conditions make it impossible to finalize the operation under satisfactory terms.

Icade and Icade Santé are exploring various options and will come back to the market in the next few days to specify the follow-up to the transaction.

ABOUT ICADE DESIRABLE PLACES TO LIVE

As an office and healthcare property investment company (portfolio worth €14.8bn on a full consolidation basis as of 06/30/2021) and a developer of homes, offices and public amenities (2020 economic revenue of €825m), Icade designs, builds, manages and invests in cities, neighbourhoods and buildings that are innovative, diverse, inclusive and connected, with a reduced carbon footprint. Desirable places to live and work. In collaboration with its stakeholders, Icade has made low carbon a strategic priority in order to reinvent real estate and create cities that are healthier, happier and more hospitable. Icade is a key player in Greater Paris and major French cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.

ABOUT ICADE SANTÉ PLACES THAT CARE FOR PEOPLE

Icade Santé is a European leader in healthcare real estate, which assists healthcare and senior services operators with the ownership and development of healthcare properties. The Group's teams have a wide range of expertise in property investment, the management of complex projects and in-depth knowledge of the challenges facing healthcare operators. As of 30 June 2021, Icade Santé owned 183 facilities, representing assets of €6.0bn (€6.4bn including duties) and a total leasable surface of approximately 2.04m sqm.

Icade and Icade Santé (for operations in France) are rated BBB+ with a stable outlook by the rating agency S&P. The text of this press release is available on the Icade website: www.icade.fr and on the Icade Santé website: https://icade-sante.fr.

CONTACTS

Anne-Sophie Lanaute Head of Financial Communication and Investor Relations at Icade +33 (0)1 41 57 70 29 [email protected]

Yoann Nguyen Investor Relations Manager at Icade Santé +33 (0)6 31 58 97 31 [email protected]

Havas Paris – France

Charlotte Pajaud-Blanchard, Press Relations Manager +33 (0)1 41 57 71 19

[email protected]

Alienor Miens (+33 6 64 32 81 75, [email protected]) Sarah Duparc (+33 6 46 72 39 99, [email protected])

Maitland – International

James Benjamin (+44 7747 113 930, [email protected]) David Sturken (+44 7990 595 913, [email protected])

Disclaimer

This press release does not contain or constitute an offer of securities for sale or an invitation or inducement to invest in securities in France, the United States or any other jurisdiction.

The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes are required to inform themselves about and to observe any such restrictions.

The securities referred to herein may not be offered or sold in the United States of America absent registration or an applicable exemption from registration under the U.S. Securities Act of 1933, as amended. The Group does not intend to register all or any portion of the offering of the securities in the United States of America or to conduct a public offering of the securities in the United States of America.